Oligomeganephrony
Oligomeganephrony is a rare renal dysplasia characterized by a reduced number of nephrons, which are significantly larger than normal. This condition is a form of congenital kidney disease and is present from birth. Oligomeganephrony is associated with significant renal impairment that can lead to chronic kidney disease (CKD) and potentially end-stage renal disease (ESRD) in severe cases. The pathophysiology of oligomeganephrony involves the underdevelopment of the metanephric blastema, a precursor to the nephrons, during fetal development. This results in a decreased number of nephrons, which then undergo compensatory hypertrophy (enlargement) in an attempt to maintain renal function.
Etiology[edit | edit source]
The exact cause of oligomeganephrony remains largely unknown, but it is believed to involve a combination of genetic and environmental factors. Genetic mutations affecting renal development may play a significant role, although specific genes have yet to be definitively linked to the condition.
Clinical Presentation[edit | edit source]
Individuals with oligomeganephrony may present with a range of symptoms related to reduced kidney function. These can include proteinuria (excess protein in the urine), hypertension (high blood pressure), and failure to thrive in infants. As the condition progresses, symptoms of chronic kidney disease, such as fatigue, decreased appetite, and growth impairment, may become evident.
Diagnosis[edit | edit source]
Diagnosis of oligomeganephrony typically involves a combination of clinical evaluation, laboratory tests, and imaging studies. Ultrasound imaging of the kidneys can reveal reduced kidney size and increased echogenicity, suggestive of the condition. A definitive diagnosis may require a renal biopsy, which can demonstrate the characteristic enlarged nephrons with reduced numbers.
Treatment[edit | edit source]
There is no cure for oligomeganephrony, and treatment focuses on managing symptoms and slowing the progression of kidney disease. This may include antihypertensive medications to control blood pressure, dietary modifications, and in advanced cases, renal replacement therapies such as dialysis or kidney transplantation.
Prognosis[edit | edit source]
The prognosis for individuals with oligomeganephrony varies depending on the severity of kidney impairment and the effectiveness of management strategies. Early detection and intervention can improve outcomes, but many individuals may eventually require renal replacement therapy.
See Also[edit | edit source]
Oligomeganephrony Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD